Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition
The ATP-binding cassette (ABC) transporters play a key role in drug pharmacokinetics. These membrane transporters expressed within physiological barriers can be a source of pharmacokinetic variability. Changes in ABC transporter expression and functionality may consequently affect the disposition of...
Saved in:
Main Authors: | Sonia Saib (Author), Xavier Delavenne (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents
by: Jaeok Lee, et al.
Published: (2021) -
Folium Sennae Increased the Bioavailability of Methotrexate through Modulation on MRP 2 and BCRP
by: Chung-Ping Yu, et al.
Published: (2021) -
Study on the Effect of Pharmaceutical Excipient PEG400 on the Pharmacokinetics of Baicalin in Cells Based on MRP2, MRP3, and BCRP Efflux Transporters
by: Dan Yang, et al.
Published: (2024) -
A phase I drug-drug interaction study to assess the effect of futibatinib on P‐gp and BCRP substrates and of P‐gp inhibition on the pharmacokinetics of futibatinib
by: Amanda Long, et al.
Published: (2024) -
Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cells
by: Xuan-Yu Chen, et al.
Published: (2024)